Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026)
Aura Biosciences (AURA) posted Other Non Operating Income of $2000.0 for Q1 2026, down 98.66% on a QoQ basis from $149000.0 in Q4 2025, and up 108.33% year-over-year from $960.0 in Q1 2025.
Aura Biosciences (AURA) Other Non Operating Income (2021 - 2026) Analysis & Trends
Aura Biosciences' Other Non Operating Income history runs 6 years deep, the most recent figure standing at $2000.0 for Q1 2026.
- Quarterly Other Non Operating Income rose 108.33% year-over-year to $2000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $102000.0 (up 191.07% YoY) and the FY2025 annual result came in at $77000.0, up 164.17% from the prior year.
- Other Non Operating Income was $2000.0 for Q1 2026 at Aura Biosciences, down from $149000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $310000.0 in Q4 2022 and bottomed at -$329000.0 in Q3 2022.
- A 5-year average of -$7352.9 and a median of -$25000.0 in 2024 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2022 — Other Non Operating Income plunged 732.69% — and 2025, when it jumped 502.7%.
- Aura Biosciences' Other Non Operating Income stood at $310000.0 in 2022, then plunged by 108.39% to -$26000.0 in 2023, then tumbled by 42.31% to -$37000.0 in 2024, then soared by 502.7% to $149000.0 in 2025, then sank by 98.66% to $2000.0 in 2026.
- Business Quant data shows AURA's Other Non Operating Income at $2000.0 in Q1 2026, $149000.0 in Q4 2025, and -$13000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Aura Biosciences | 485.62 Mn | 400.83 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2,000.00 |
| Dec 31, 2025 | 149,000.00 |
| Sep 30, 2025 | -13,000.00 |
| Jun 30, 2025 | -36,000.00 |
| Mar 31, 2025 | -24,000.00 |
| Dec 31, 2024 | -37,000.00 |
| Sep 30, 2024 | -25,000.00 |
| Jun 30, 2024 | -26,000.00 |
| Mar 31, 2024 | -32,000.00 |
| Dec 31, 2023 | -26,000.00 |
| Sep 30, 2023 | -5,000.00 |
| Jun 30, 2023 | -32,000.00 |
| Mar 31, 2023 | -13,000.00 |
| Dec 31, 2022 | 310,000.00 |
| Sep 30, 2022 | -329,000.00 |
| Jun 30, 2022 | 56,000.00 |
| Mar 31, 2022 | -44,000.00 |
| Sep 30, 2021 | 52,000.00 |